Bal Pharma Ltd.
BALPHARMA Share PricePharmaceuticals & Drugs
₹74.37
0.6 (0.8%)
As on December 4, 2025
Exchange Scrips: BSE524824NSEBALPHARMAISININE083D01012
Market Cap ₹ 119 Cr
P/E Ratio 16.41
Dividend Yield 0.16 %
Performance
Market performance
Open74.95
High74.95
Volumes2,528
Prev74.37
Low73.6
As on2025-12-04
Historical performance
1 Year High132
3 Year High157.98
5 Year High157.98
1 Year Low73.01
3 Year Low63.35
5 Year Low49.55
Fundamentals
Company Valuation
Market Cap (₹Cr)
119
Face Value (₹)
10
P/E Ratio
16.41
Dividend Yield
0.16 %
Investment Returns
1 Year
-39.5%
3 Years
-14.2%
5 Years
35.2%
10 Years
-47.7%
Technicals
| Indicators | Value | Signal |
|---|---|---|
| 5-DMA | 74.91 | Bearish |
| 10-DMA | 75.21 | Bearish |
| 20-DMA | 77.59 | Bearish |
| 50-DMA | 80.64 | Bearish |
| 100-DMA | 86.52 | Bearish |
| 200-DMA | 92.1 | Bearish |
Shareholding Pattern
| Field | Sep-2025 | Jun-2025 | Mar-2025 | Dec-2024 | Sep-2024 |
|---|---|---|---|---|---|
| Promoters | 11 | 11 | 11 | 11 | 11 |
| Foreign Investors | 3 | 3 | 3 | 3 | 3 |
| Domestic Investors | 8 | 8 | 8 | 8 | 8 |
| Public Investors | 15763 | 15815 | 15712 | 15656 | 15996 |
| Government | --- | --- | --- | --- | --- |
Financials
Below figures are in Rs. Crores
Balance Sheet
Below figures are in Rs. Crores
Cash Flow
Below figures are in Rs. Crores
0%
Negative
Neutral
Positive
- The stock has a PE ratio of 16.41.
- 3Y Stock Price CAGR of the stock is -6.1.
- The stock has a beta of 0.7.
- In the last financial year, the company had an EBITDA of ₹320 Million.
- The company generated revenue of ₹3031 Million in the previous financial year.
Bal Pharma Ltd.
74.370.6 (0.8%)
₹
Investment Amount: ₹ 1000000
Current Value: ₹ 606854.3
No. of Shares: 8160 (Approx)
Performance:-39.3%
P/L: ₹-393145.7
Top Gainers
Peer Comparison
Get Your Portfolio Reviewed
